This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Sung Ho Hahm
CEO at Rophibio Inc.

Profile

Dr. Hahm received Ph.D. degree in biomedical science from Univ South Carolina followed by Postdoctoral training at National Institutes of Health and Staff Fellow at Johns Hopkins Medical School. He has been working as CEO of Rafagen in USA and then as the Founder and CEO of Rophibio in Korea. He has accumulated over 25 years of experience in cellular and molecular biology research and development. At Rophibio, he has been leading technology development in CHO cell-based cell line development and upstream process development for the company’s biosimilars and biopharmaceuticals candidates.

Agenda Sessions

  • Cell Line Development with High Titer and Long Term Stability

    11:20am